Clinical trials of Covaxin approved for children between 2 – 18 years
The Drugs Controller General of India (DCGI) has provided approval to Hyderabad based-Bharat Biotech for conducting clinical trials on children for the Covid-19 vaccine Covaxin, thereby becoming the first Covid-19 vaccine which will be subjected to testing on children in India. DCGI has given the approval to conduct trials for children between the age group…